Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2025 Filed Feb 12, 2025 16:12 UTC |
Archimedes Tech SPAC Sponsors II LLC10% owner
|
PurchaseWarrants to purchase ordinary shares · Derivative | 265,000 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001437749-25-003570 · rdgdoc.xml · derivative · entry 2 Archimedes Tech SPAC Sponsors II LLC · CIK 0002055303 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,000 Underlying: Ordinary shares · 265,000 shares Expires not disclosed F1 · price: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. F2 · derivative.exercise_date: The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. F2 · derivative.expiration_date: The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. Read SEC document |
| February 12, 2025 Filed Feb 12, 2025 16:12 UTC |
Archimedes Tech SPAC Sponsors II LLC10% owner
|
PurchaseOrdinary shares | 530,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-003570 · rdgdoc.xml · nonDerivative · entry 1 Archimedes Tech SPAC Sponsors II LLC · CIK 0002055303 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,280,000 F1 · price: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. Read SEC document |
| February 12, 2025 Filed Feb 12, 2025 21:12 UTC |
Long LongDirector · Chief Executive Officer · 10% owner
|
PurchaseWarrants to purchase ordinary shares · Derivative | 265,000 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001437749-25-003569 · rdgdoc.xml · derivative · entry 2 Long Long · CIK 0001793151 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 265,000 Underlying: Ordinary shares · 265,000 shares Expires not disclosed F1 · price: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. Long Long is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Long disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein. F2 · derivative.exercise_date: The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. F2 · derivative.expiration_date: The warrants included in the private units will become exercisable at the later of 12 months from the closing of the Issuer's initial public offering and 30 days after the completion of its initial business combination and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation. F1 · ownership.nature: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. Long Long is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Long disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein. Read SEC document |
| February 12, 2025 Filed Feb 12, 2025 21:12 UTC |
Long LongDirector · Chief Executive Officer · 10% owner
|
PurchaseOrdinary shares | 530,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-003569 · rdgdoc.xml · nonDerivative · entry 1 Long Long · CIK 0001793151 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 6,280,000 F1 · price: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. Long Long is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Long disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein. F1 · ownership.nature: Reflects the 530,000 private units owned by Archimedes Tech SPAC Sponsors II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one-half of one warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased at $10.00 per unit for an aggregate purchase price of $5,300,000. Long Long is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Mr. Long disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.